IDENTIFICATION OF PLASMA HYDROXYSPHINGOLIPIDS AS BIOMARKERS OF DEMYELINATION AND NEURODEGENERATION UNDERLYING PHYSICAL FUNCTION DECLINE IN OLDER ADULTS